Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

255.55 2.27 +0.90%
Market cap
$610.4B
P/E
29.6×
Fwd P/E
24.9×
Dividend yield
2.07%
F-score
3/9
Altman Z
4.78
Beneish M
−2.26
Dividend safety
78/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
19.70 357.00 23.00 25.89 28.56 21.90 26.44 11.58 24.93 18.73
Piotroski F-Score
7 4 9 6 4 8 5 6 6 3
P/S ratio
4.41 4.90 4.24 4.70 5.02 5.72 5.85 4.76 3.92 5.29
Altman Z-Score
5.10 4.21 4.27 4.31 3.99 4.34 4.25 4.59 4.01 4.78
Altman Z″-Score (non-manufacturers)
6.39 4.09 4.43 4.08 3.69 4.21 3.67 4.69 4.41 4.71
P/FCF ratio
18.87 19.11 15.92 16.64 20.22 22.00 26.39 21.78 16.97 24.40
Beneish M-Score
(2.51) (2.80) (2.68) (2.69) (2.79) (2.54) (2.65) (2.71) (2.75) (2.26)
P/Operating CF
47.66 61.39 55.42 60.31 49.66 78.55 87.44 51.54 49.86 68.16
Dividend Safety Score
— — — — — — — — — 78
P/B ratio
4.36 6.23 5.79 6.49 6.55 6.08 6.09 5.89 4.87 6.11
EV/Sales
4.14 5.06 4.34 4.79 5.11 5.70 5.91 4.79 3.99 5.49
EV/EBITDA
12.07 15.72 13.34 15.71 17.55 16.74 17.43 16.61 13.57 12.29
EV/FCF
17.71 19.75 16.29 16.95 20.58 21.92 26.65 21.94 17.27 25.35
Current Ratio
2.47 1.41 1.47 1.26 1.21 1.35 0.99 1.16 1.11 1.03
Net Debt/EBITDA
(0.79) 0.50 0.30 0.29 0.31 (0.06) 0.17 0.12 0.23 0.46
Debt/Equity
0.32 0.51 0.46 0.45 0.52 0.41 0.35 0.38 0.43 0.48
ROE
23.60% 1.99% 25.51% 25.36% 23.97% 30.41% 23.79% 48.29% 20.06% 35.03%
ROA
12.05% 0.87% 9.86% 9.73% 8.85% 11.70% 9.71% 19.81% 8.09% 14.13%
ROIC
24.29% 15.23% 16.60% 16.24% 14.58% 16.56% 14.86% 13.12% 13.44% 20.19%
Return on Tangible Assets
30.26% 4.40% 48.05% 56.06% 53.49% 60.14% 102.67% 129.66% 53.91% 108.66%
Average Days of Receivables
59.40 64.41 63.08 64.41 60.00 70.84 64.06 63.75 60.99 66.57
Earnings Yield
5.08% 0.28% 4.35% 3.86% 3.50% 4.57% 3.78% 8.63% 4.01% 5.34%
Free Cash Flow Yield
5.30% 5.23% 6.28% 6.01% 4.95% 4.55% 3.79% 4.59% 5.89% 4.10%
Free Cash Flow per Share
6.14 7.28 8.11 8.76 7.78 7.78 6.75 7.34 8.52 8.48
Book value per Share
25.73 22.35 22.28 22.48 24.03 28.12 29.26 27.15 29.70 33.87
Free Cash Flow
16,808.00 19,609.00 21,734.00 23,183.00 20,494.00 20,469.00 17,728.00 18,606.00 20,517.00 20,418.00
EV/EBIT
14.24 20.39 18.05 21.83 25.09 23.11 23.47 23.88 18.87 14.95
Other line items

Show all line items

Columns are period end dates · fundamentals updated 14 Oct 2026